NCT02263508 Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma Status TERMINATED Phase PHASE3
NCT02257476 Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02253654 Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis Status COMPLETED Phase PHASE4
NCT02246218 A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders Status COMPLETED Phase PHASE4
NCT02244112 A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT02236988 Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men Status COMPLETED Phase PHASE1
NCT02235740 A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2) Status TERMINATED Phase PHASE1
NCT02227914 Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT02222155 Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis Status COMPLETED Phase PHASE2
NCT02211131 Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma Status COMPLETED Phase PHASE2
NCT02207634 Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects Status COMPLETED Phase PHASE3
NCT02191150 Study of Haemodialysis Patients Switching From Aranesp to Biosimilar Status COMPLETED Phase N/A
NCT02189837 Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody Status COMPLETED Phase PHASE3
NCT02187354 Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL Status NO_LONGER_AVAILABLE Phase N/A
NCT02186171 A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis Status COMPLETED Phase PHASE3
NCT02185911 Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis Status COMPLETED Phase N/A
NCT02178475 Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy Status COMPLETED Phase N/A